2seventy bio, Inc. (TSVT)

2seventy bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	71.2	100.39	91.5	54.52	248.12	44.3
Revenue Growth (YoY)	-42.90%	9.72%	67.81%	-78.03%	460.15%	-18.84%
Cost of Revenue	15.89	16.92	16.58	11.84	5.4	2.98
Gross Profit	55.31	83.47	74.92	42.69	242.73	41.32
Selling, General & Admin	61.35	69.41	79.45	93.51	90.9	81.65
Research & Development	206.44	230.76	248.74	252.62	296.47	297.65
Other Operating Expenses	31.16	20.67	9.64	10.07	0	0
Operating Expenses	298.95	320.84	337.83	356.19	387.36	379.29
Operating Income	-243.64	-237.37	-262.91	-313.51	-144.64	-337.97
Other Expense / Income	-20.42	-19.8	-8.76	-21.3	-24.52	-17.38
Pretax Income	-223.22	-217.57	-254.15	-292.21	-120.11	-320.59
Net Income	-223.22	-217.57	-254.15	-292.21	-120.11	-320.59
Shares Outstanding (Basic)	52	49	36	23	23	23
Shares Outstanding (Diluted)	52	49	36	23	23	23
Shares Change	19.79%	38.27%	51.65%	0.56%	-	-
EPS (Basic)	-4.35	-4.42	-7.13	-12.44	-5.14	-13.72
EPS (Diluted)	-4.35	-4.42	-7.13	-12.44	-5.14	-13.72
Free Cash Flow	-167.87	-180.72	-258.95	-218.43	-90.05	-267.72
Free Cash Flow Per Share	-3.22	-3.67	-7.27	-9.29	-3.85	-11.46
Gross Margin	77.68%	83.15%	81.88%	78.29%	97.83%	93.28%
Operating Margin	-342.19%	-236.46%	-287.34%	-575.01%	-58.29%	-762.99%
Profit Margin	-313.51%	-216.73%	-277.77%	-535.95%	-48.41%	-723.75%
Free Cash Flow Margin	-235.77%	-180.03%	-283.02%	-400.63%	-36.29%	-604.39%
EBITDA	-213.09	-207.29	-242.62	-275.86	-106.93	-308.01
EBITDA Margin	-299.27%	-206.49%	-265.17%	-505.97%	-43.09%	-695.34%
Depreciation & Amortization	10.14	10.29	11.53	16.35	13.19	12.59
EBIT	-223.22	-217.57	-254.15	-292.21	-120.11	-320.59
EBIT Margin	-313.51%	-216.73%	-277.77%	-535.95%	-48.41%	-723.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).